The Discounted Cash Flow (DCF) valuation of Alpine Immune Sciences Inc (ALPN) is (88.37) USD. With the latest stock price at 64.97 USD, the upside of Alpine Immune Sciences Inc based on DCF is -236.0%.
Based on the latest price of 64.97 USD and our DCF valuation, Alpine Immune Sciences Inc (ALPN) is a sell. selling ALPN stocks now will result in a potential gain of 236.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.9% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (287.15) - (52.70) | (88.37) |
| Upside | -542.0% - -181.1% | -236.0% |